Voleon Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.35M Sell
464,452
-21,600
-4% -$389K 0.17% 129
2026
Q2
$8.41M Sell
486,052
-300,712
-38% -$4.12M 0.15% 139
2026
Q1
$9.8M Sell
786,764
-73,918
-9% -$992K 0.21% 108
2025
Q4
$10.8M Buy
860,682
+448,503
+109% +$5.13M 0.23% 88
2025
Q3
$4.13M Buy
412,179
+350,114
+564% +$3.14M 0.1% 204
2025
Q2
$502K Buy
62,065
+15,677
+34% +$118K 0.03% 321
2025
Q1
$389K Sell
46,388
-9,574
-17% -$79.9K 0.03% 276
2024
Q4
$443K Buy
+55,962
New +$469K 0.03% 258

Other funds holding AMRX

Voleon Capital Management's AMRX Position: Q3 2026 in Review

Voleon Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 4.4% in Q3 2026, selling an estimated $389K and leaving 464,452 shares worth $9.35M. The position accounts for 0.17% of the portfolio, ranked #129.

Voleon Capital Management first reported a position in AMRX in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.8M in Q4 2025. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Voleon Capital Management held 464,452 shares of Amneal Pharmaceuticals worth $9.35M as of Q3 2026.
  • Voleon Capital Management sold 21,600 Amneal Pharmaceuticals shares in Q3 2026, an estimated $389K.
  • Amneal Pharmaceuticals made up 0.17% of Voleon Capital Management's portfolio in Q3 2026, its #129 holding.
  • Voleon Capital Management first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • Voleon Capital Management's Amneal Pharmaceuticals position peaked at $10.8M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.